株式会社PURMX THERAPEUTICS

Hiroshima, JP · 4 known investors

PURMX Therapeutics develops nucleic acid medicines as anti-cancer drugs based on microRNA research and the concept of an "ageing switch" to induce ageing in cancer cells. The Japanese pharmaceutical venture handles drug development functions including non-clinical research, clinical development, CMC, and regulatory affairs.

BiotechHealthtechLongevityMedical Devices